ViewMind Applauded by Frost & Sullivan for Revolutionizing Brain Health Assessment and Care with Its Ocular Digital Phenotyping Solution

ViewMind’s Ocular Digital Phenotyping solution is a holistic approach to brain and mental health that builds trust through technology, enabling universal, language-free usage for fast and accurate results.

SAN ANTONIO, July 23, 2024 /PRNewswire/ — Frost & Sullivan recently analyzed the brain, mental, and neurological diagnosis and treatment industry and, based on its results, recognizes ViewMind with the 2024 North American Technology Innovation Leadership Award. The company stands at the forefront of precision brain health and neurology, offering easy-to-perform and non-invasive assessments. Specializing in measuring ocular movement alterations, the company provides a unique window into brain health. Its digital assessments boast high sensitivity and specificity, positioning it as a pivotal contributor to advancing precision drug development and patient care. The company aims to revolutionize central nervous system drug development and precision patient care by providing scalable, affordable, and non-invasive brain health markers. Its approach accurately assesses cognitive domains and the health of associated brain regions, offering a comprehensive view of neurocognitive health.

ViewMind’s patented ocular digital phenotyping uses a head-mounted display and sensors to track eye movements in response to visual stimuli. It employs advanced statistical models to analyze data, detecting even minor cognitive alterations or changes in high-level motor function. The generated report provides valuable insights into the patient’s cognitive condition, enabling physicians to make informed decisions. This innovative solution combines advanced testing with a user-friendly experience and has broad applications, such as helping pharmaceutical companies pre-screen study participants and measure drug impacts, as well as aiding healthcare institutions assess and monitor patients’ brain health and treatment effectiveness.

Deepali Sathe, senior industry analyst at Frost & Sullivan, observed, “ViewMind is a pioneering force in neuroscience and technology that is poised to revolutionize brain and mental health diagnostics and drug development. With its transformative vision and dedication to accuracy, ViewMind leads the way in brain and mental health diagnostics and treatment.”

ViewMind’s technology is based on the fascinating connection between eye movements and brain function. Although the eye is primarily responsible for visual perception, it also plays a crucial role in acquiring visual information. The eyes move precisely through fixations and saccades to gather information that reveals specific patterns in brain function. Understanding this has significant implications for the diagnosis and comprehension of neuropsychiatric and neurodegenerative disorders. The company designed its test for controlled environments, typically a quiet room, to ensure result accuracy. Training to administer the test is straightforward and can be completed online in less than an hour. The test is language-free and relies on shapes and eye movements, making it universally applicable regardless of age, culture, or educational background. The company’s dedication to accuracy and its forward-thinking approach make it a pivotal player in the future of healthcare technology.

“ViewMind’s innovative approach to measuring brain health stands at the forefront of transformative advancements in brain and mental health diagnosis and care. The company’s commitment to precision and accessibility through its digital assessments and non-invasive technology aligns with this evolving landscape. ViewMind is poised to lead the way in transforming brain and mental health diagnostics and treatment by enabling improved patient outcomes and revolutionizing brain health assessment and care,” said Natalia Casanovas, best practices research analyst at Frost & Sullivan.

Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality that is gaining rapid acceptance in the market. The award recognizes the quality of the solution and the customer value enhancements it enables.

Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, megatrends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion. Contact us: Start the discussion.

Contact:

Camila Tinajero
P: + 549 11 6713 2748
E: Camila.Tinajero@frost.com

About ViewMind

ViewMind is a global leader in precision measurement of ocular movement alterations, a window into brain and mental health. With high sensitivity and specificity, ViewMind’s digital assessments can contribute to advancing precision drug development and precision patient care. For more information about ViewMind.

Contact:

Craig Davidson
Sermelo PR
P: +44 20 7240 6800
E: craig.davidson@sermelo.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/viewmind-applauded-by-frost–sullivan-for-revolutionizing-brain-health-assessment-and-care-with-its-ocular-digital-phenotyping-solution-302201279.html

SOURCE Frost & Sullivan